RecruitingNCT06953180

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction

Sponsor

Asfendiyarov Kazakh National Medical University

Enrollment

6,720 participants

Start Date

Mar 3, 2025

Study Type

OBSERVATIONAL

Conditions

Chronic Kidney Diseases Type 2 Diabetes Obesity (Disorder)Cardiovascular Diseases (CVD)Chronic Respiratory Diseases

Summary

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Eligibility

Min Age: 18 YearsMax Age: 69 Years

Plain Language Summary

Simplified for easier understanding

This study investigates how lifestyle, environment, and biological markers (including epigenetics — changes in how genes are expressed) are linked to the development of chronic diseases such as heart disease and diabetes in Kazakhstan. Researchers will collect health data from a large number of adults across the country. **You may be eligible if...** - You are between 18 and 69 years old - You live in any of the 17 regions of Kazakhstan - You are willing to provide informed consent and participate in data collection **You may NOT be eligible if...** - You are under 18 or over 69 years old - You decline to give consent or do not complete the required data collection procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.